Indonesia Health Minister Says U.S. Used Bird Flu Strain For Profit
This article was originally published in PharmAsia News
Indonesia's health minister says the United States and a UN group exploited her country's strain of the avian flu virus for commercial gain. Minister Siti Fadhilah Supari said Indonesia sent the virus to the United States for humanitarian purposes, but it was developed into vaccines and sold to developing countries for millions of dollars. Supari, who resisted giving the virus to the World Health Organization last year, has published a book on that experience. (Click here for more
You may also be interested in...
With Roche's oral spinal muscular atrophy therapy Evrysdi off to a strong start after its recent US launch, Novartis is switching its priorities for rival RNA-splicing drug branaplam and putting it into a Phase IIb trial for Huntington's disease.
Nuvation started in 2018 and raised a $275m series A round in 2019. Now it is merging with the EcoR1 Capital-sponsored SPAC Panacea Acquisition Corp. and raising $500m in equity capital.
US FDA investigators' increased focus on aseptic operations is resulting in more Form 483 observations of microbiological contamination issues over the past few years.